Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies

M. L. Tetef, T. W. Synold, W. Chow, L. Leong, K. Margolin, R. Morgan, J. Raschko, S. Shibata, G. Somlo, Y. Yen, S. Groshen, K. Johnson, H. J. Lenz, D. Gandara, J. H. Doroshow

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences